Fleurent M, Gingras A C, Sonenberg N, Meloche S
Centre de Recherche, Hôtel-Dieu de Montréal and Department of Pharmacology, University of Montreal, Montreal, Quebec, Canada H2W 1T8.
J Biol Chem. 1997 Feb 14;272(7):4006-12. doi: 10.1074/jbc.272.7.4006.
To investigate the molecular basis of the hypertrophic action of angiotensin II (AII) in vascular smooth muscle cells (SMC), we have examined the ability of the hormone to regulate the function of the translational repressor 4E-binding protein 1 (4E-BP1). Addition of AII to quiescent aortic SMC potently increased the phosphorylation of 4E-BP1 as revealed by a decreased electrophoretic mobility and an increased phosphate content of the protein. The stimulation of 4E-BP1 phosphorylation was maximal at 15 min and persisted up to 120 min. Results from affinity chromatography on m7GTP-agarose demonstrated that AII-induced phosphorylation of 4E-BP1 promotes its dissociation from eIF4E in target cells. Further characterization of 4E-BP1 phosphorylation by phosphoamino acid analysis and phosphopeptide mapping revealed that 4E-BP1 is phosphorylated on eight distinct peptides containing serine and threonine residues in AII-treated cells. The combination of results obtained from kinetics experiments, phosphopeptide analysis of in vitro and in vivo phosphorylated 4E-BP1, and pharmacological studies with the MAP kinase kinase inhibitor PD 98059 provided strong evidence that the MAP kinases ERK1/ERK2 are not involved in the regulation of 4E-BP1 phosphorylation in aortic SMC. Together, our results demonstrate that AII treatment of vascular SMC leads to hyperphosphorylation of the translational regulator 4E-BP1 and to its dissociation from eIF4E by a MAP kinase-independent mechanism.
为了研究血管紧张素II(AII)在血管平滑肌细胞(SMC)中肥大作用的分子基础,我们检测了该激素调节翻译抑制因子4E结合蛋白1(4E-BP1)功能的能力。向静止的主动脉SMC中添加AII可显著增加4E-BP1的磷酸化水平,这可通过蛋白质电泳迁移率降低和磷酸盐含量增加来揭示。4E-BP1磷酸化的刺激作用在15分钟时达到最大,并持续至120分钟。m7GTP-琼脂糖亲和层析结果表明,AII诱导的4E-BP1磷酸化促进其在靶细胞中与eIF4E解离。通过磷酸氨基酸分析和磷酸肽图谱对4E-BP1磷酸化进行的进一步表征显示,在AII处理的细胞中,4E-BP1在含有丝氨酸和苏氨酸残基的八个不同肽段上发生磷酸化。动力学实验、体外和体内磷酸化4E-BP1的磷酸肽分析以及使用丝裂原活化蛋白激酶激酶抑制剂PD 98059的药理学研究结果共同提供了有力证据,表明丝裂原活化蛋白激酶ERK1/ERK2不参与主动脉SMC中4E-BP1磷酸化的调节。总之,我们的结果表明,AII处理血管SMC会导致翻译调节因子4E-BP1的过度磷酸化,并通过一种不依赖丝裂原活化蛋白激酶的机制使其与eIF4E解离。